Growth inhibition of a human lung adenocarcinoma cell line by genetic complementation with chromosome 11

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3243-3251

  O'Briant, Kathy ^a   Jolicoeur, Ethel ^a   Garst, Jennifer ^a   Campa, Mike ^a   Schreiber, Gilbert ^a   Bepler, Gerold ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allele loss; Chromosome 11; Genetic complementation; Lung cancer; Tumor suppressor gene

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER INHIBITION; CARCINOGENICITY; CHROMOSOME 11; CHROMOSOME 11P; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GENETIC COMPLEMENTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; ALLELES; ANIMALS; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 11; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GENETIC COMPLEMENTATION TEST; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030728768     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parker SL, Tong T, Bolden S, and Wingo PA: Cancer statistics 1996. Calif Cancer J Clin 46: 5-27, 1996.
2. Eddy DM: Screening for lung cancer. Ann Int Med 111: 232-237, 1989.
3. Ihde DC: Chemotherapy of lung cancer. N Engl J Med 327: 1434-1441, 1992.
4. Bepler G and Garcia-Blanco MA: Three tumor-suppressor regions on chromosome 1 1p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci USA 91: 5513-5517, 1994.
5. Bepler G and Koehler A: Multiple chromosomal aberrations and chromosome 11p allelotyping in lung cancer cell lines. Cancer Genet Cytogenet 84: 25-30, 1995.
6. O'Briant KC and Bepler G: Delineation of the centromeric and telomeric chromosome segment 11p1S.5 lung cancer suppressor regions LOH1 1A and LOH11B. Genes Chromosom Cancer 18: 111-114, 1997.
7. Shiraishi M, Morinaga S, Noguchi M, Shimosato Y, and Sekiya T: Loss of genes on the short arm of chromosome 11 in human lung carcinomas. Jpn J Cancer Res 78: 1302-1308, 1987.
8. Weston A, Willey JC, Modali R, Sugimura H, McDowell EM, Resau J, Light B, Haugen A, Mann DL, Trump BF, and Harris CC: Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, largecell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci USA 86: 5099-5103, 1989.
9. Skinner MA, Vollmer R, Huper G, Abbott P, and Iglehart JD: Loss of heterozygosity for genes on 11p and the clinical course of patients with lung carcinoma. Cancer Res 50: 2303-2306, 1990.
10. Ludwig CU, Raefle G, Dalquen P, Stulz P, Stahel R, and Obrecht JP: Allelic loss on the short arm of chromosome 11 in non-small cell lung cancer. Int J Cancer 49: 661-665, 1991.
11. Whang-Peng J, Knutsen T, Gazdar A, Steinberg SM, Oie H, Linnoila I, Mulshine J, Nau M, and Minna JD: Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer. Genes Chromosom Cancer 3: 168-188, 1991.
12. Satoh H, Lamb PW, Dong J-T, Everitt J, Boreiko C, Oshimura M, and Barrett JC: Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer. Molec Carcinogen 7: 157-164, 1993.
13. Fong KM, Zimmerman PV, and Smith PJ: Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer. Genes Chromosom Cancer 10: 183-189, 1994.
14. Zenklusen JC, Oshimura M, Barrett JC, and Conti CJ: Human chromosome 11 inhibits tumorigenicity of a murine squamous cell carcinoma cell line. Genes Chrom Cancer 13: 47-53, 1995.
15. Fournier REK and Ruddle FH: Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc Natl Acad Sci USA 74: 319-323, 1977.
16. Koi M, Morita H, Yamada H, Satoh H, Barrett JC, and Oshimura M: Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol Carcinog 2: 12-21, 1989.
17. Dowdy SF, Scanlon DJ, Fasching CL, Casey G, and Stanbridge EJ: Irradiation microcell-mediated chromosome transfer (XMMCT): the generation of specific chromosomal arm deletions. Genes Chrom Cancer 2: 318-327, 1990.
18. Bepler G, Koehler A, Kiefer P, Havemann K, Beisenherz K, Jaques G, Gropp C, and Haeder M: Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines. Differentiation 37: 158-171, 1988.
19. Negrini M, Sabbioni S, Possati L, Raatan S, Corallini A, Barbati-Brodano G, and Croce C: Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosome 6 and 11. Cancer Res 54: 1331-1336, 1994.
20. Negrini M, Sabbioni S, Haldar S, Possati L, Castagnoli A, Corallini A, BarbatiBrodano G, and Croce C: Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res 54: 1818-1824, 1994.
21. Ichikawa T, Nihei N, Suzuki H, Oshimura M, Emi M, Nakamura Y, Hayata I, Isaacs J, and Shimazaki J: Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 54: 2299-2302, 1994.
22. Sanchez Y, Lovell M, Marin MC, Wong PE, Wolf-Ledbetter ME, McDonnell TJ, and Killary AM: Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter-q11. Proc Natl Acad Sci USA 93: 2551-2556, 1996.
23. Ichikawa T, Ichikawa Y, Dong J, Hawkins A, Griffin C, Isaacs W, Oshimura M, Barrett J, and Isaacs J: Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 52: 3486-3490, 1992.
24. Berube N, Speevak M, and Chevrette M: Suppression of tumorigenicity of human prostate cancer cells by introduction of human chromosome del(12)(q13). Cancer Res 54: 3077-3081, 1994.
25. Koi M, Umar A, Chauhan D, Cherian S, Carethers J, Kunkel T, and Boland C: Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLHI mutation. Cancer Res 54: 4308-4312, 1994.
26. Negrini M, Castagnoli A, Pavan J, Sabbioni S, Araujo D, Corallini A, Gualandi F, Rimessi P, Bobfatti A, Giunta C, Sensi A, Stanbridge E, and Barbanti-Brodano G: Suppression of tumorigenicity and anchorage-independent growth of BK virustransformed mouse cells by human chromosome 11. Cancer Res 52: 1297-1303, 1992.
27. Saxon PJ, Srivatsan ES, and Stanbridge EJ: Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J 15: 3461-3466, 1986.
28. Srivatsan ES, Benedict WF, and Stanbridge EJ: Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrides. Cancer Res 46: 6174-6179, 1986.
29. Weissman B, Saxon P, Pasquale S, Jones G, Geiser A, and Stanbridge E: Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236: 175-180, 1987.
30. Koi M, Johnson LA, Kalikin LM, Little PFR, Nakamura Y, and Feinberg AP: Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. gcience 260: 361-364, 1993.